As of December 2024 MoonLake Immunotherapeutics has a market cap of A$5.37 Billion. This makes MoonLake Immunotherapeutics the world's 3368th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 30th, 2024 the market cap of MoonLake Immunotherapeutics was reported to be: